Skip to main content

Table 1 Patient demographics and clinical characteristics (N = 417 patients)

From: Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents– a real-world cross-sectional study from Switzerland (SAKK 95/16)

Median age (min., max.) 69 (30, 95)
Underlying tumor entity N (%)
 Breast cancer 169 (41)
 Prostate cancer 106 (25)
 Lung cancer 62 (15)
 Other 80 (19)
Disease status N (%)
 Progressing 112 (27)
 Stable 302 (72)
 Missing 3 (1)
ECOG performance status N (%)
 0 140 (34)
 1 210 (50)
 2 53 (13)
 3 14 (3
Cancer treatments (multiple) N (%)
 Chemotherapy 258 (62)
 Endocrine therapy 264 (63)
 Targeted treatments 100 (24)
 Immunotherapy 82 (20)
 Radiotherapy 251 (60)
 Radioisotope therapy 34 (8)
 Surgery 207 (50)
 Unknown 6 (1)
Employment status N (%)
 Working part time 67 (16)
 Working full time 38 (9)
 Unemployed 46 (11)
 Retired 261 (63)
 Unknown 5 (1)